OTC Pharmaceuticals - Pakistan

  • Pakistan
  • Revenue in the OTC Pharmaceuticals market amounts to US$524.30m in 2024. The market is expected to grow annually by 6.79% (CAGR 2024-2029).
  • The market's largest segment is the segment Analgesics with a market volume of US$123.40m in 2024.
  • In global comparison, most revenue is generated in the United States (US$41,240m in 2024).
  • In relation to total population figures, per person revenues of US$2.14 are generated in 2024.
  • In the OTC Pharmaceuticals market, 17.6% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in Pakistan is experiencing steady growth due to various factors such as changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in the OTC Pharmaceuticals market in Pakistan are shifting towards self-medication and convenience.

With increasing awareness about health and wellness, consumers are becoming more proactive in managing their health. They are seeking over-the-counter medications that can provide quick relief for common ailments such as headaches, colds, and allergies. Additionally, the convenience of purchasing OTC medications without a prescription is also driving customer preferences in Pakistan.

Trends in the OTC Pharmaceuticals market in Pakistan are influenced by global and regional market dynamics. One significant trend is the increasing availability of generic OTC medications. Generic medications are more affordable compared to branded products, making them a popular choice among price-conscious consumers in Pakistan.

Another trend is the growing demand for natural and herbal remedies. Consumers are increasingly looking for OTC medications made from natural ingredients, as they perceive them to be safer and more effective. Local special circumstances in Pakistan also contribute to the development of the OTC Pharmaceuticals market.

The country has a large population with a high prevalence of common ailments such as respiratory infections, digestive disorders, and skin conditions. This creates a significant market opportunity for OTC medications that can address these health issues. Moreover, the widespread availability of OTC medications in local pharmacies and convenience stores makes them easily accessible to consumers across the country.

Underlying macroeconomic factors play a crucial role in shaping the OTC Pharmaceuticals market in Pakistan. The country's growing middle class and increasing disposable income levels have led to higher healthcare spending. As a result, consumers are willing to invest in OTC medications to manage their health and well-being.

Additionally, the government's focus on healthcare infrastructure development and the promotion of self-medication further support the growth of the OTC Pharmaceuticals market in Pakistan. In conclusion, the OTC Pharmaceuticals market in Pakistan is witnessing growth due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. With increasing awareness about health and wellness, consumers are opting for OTC medications that provide quick relief and convenience.

The availability of generic and natural remedies, along with the country's large population and rising healthcare spending, further contribute to the market's development.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)